Abstract
Genome-wide association studies (GWAS) have identified THADA as one of the susceptibility genes for polycystic ovary syndrome (PCOS). Single nucleotide polymorphisms (SNPs) in the THADA gene showed significant over-transmission in PCOS and strong correlations with testosterone level. However, there was insufficient evidence to verify the effect of THADA in vivo on female reproductive system. In this study, we investigated the impacts of Thada ablation on ovarian function and reproductive outcomes with knockout (KO) mice. The results showed that the Thada deletion was insufficient to affect ovarian folliculogenesis, steroidogenesis, and female fertility. Additionally, we stressed the mice with high-fat-high-sugar diet (HFHS). In this case, the KO mice still merely had a negligible impact on ovarian function. These findings indicated that Thada deficiency was dispensable for female fertility in mice, which enriched our knowledge about in vivo functions of PCOS susceptibility genes.
Introduction
Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder in women of reproductive age, characterized by high androgen levels, irregular cycles, and polycystic ovaries. Genome-wide association studies (GWAS) have consistently identified the THADA gene as a primary susceptibility locus for PCOS, particularly in Han Chinese and European populations. However, correlation is not causation. While certain variants in THADA are associated with higher testosterone levels, it remained unclear whether the gene actually drives the disease. This study seeks to bridge the gap between genetic association and biological function by testing if losing Thada function in a mouse model causes reproductive failure or PCOS-like symptoms.
Methods
The researchers employed CRISPR-Cas9 technology to delete exons 8 through 11 of the Thada gene in C57BL/6J mice, creating a global knockout (KO) model. They monitored developmental milestones such as the age of puberty (vaginal opening) and estrous cycle regularity. Overall fertility was evaluated through long-term breeding assays measuring litter size and pup frequency.
Ovarian health was assessed via histological staining (H&E) to count follicles and evaluate the response to superovulation. Hormonal profiles, including testosterone, estrogen, and progesterone, were measured via radioimmunoassay. To mimic the interaction of genetics and environment, a subset of mice was fed a High-Fat-High-Sugar (HFHS) diet for 10 weeks to see if metabolic stress would unmask a PCOS phenotype in the KO mice.
Results
Normal Development and Fertility
Thada KO mice were born at the expected Mendelian ratios and grew normally, reaching puberty at the same time as their wild-type (WT) siblings. Breeding assays demonstrated that fertility was maintained, with no significant differences in litter size (averaging ~6-7 pups) or the interval between litters compared to WT controls.
Ovarian and Hormonal Stability
Histological analysis showed normal follicle counts and healthy corpus luteum formation, indicating successful ovulation. While adult KO mice showed a slight elevation in circulating testosterone, this increase was insufficient to disrupt the estrous cycle or follicle development. Estrogen and progesterone levels remained comparable to WT. Furthermore, KO mice produced a similar number of mature oocytes following hormonal stimulation, with no defects in polar body extrusion.
Resilience to Metabolic Stress
One of the most notable findings was that the HFHS diet—which typically impairs ovarian function—did not affect KO mice differently than WT mice. This implies that Thada does not play a critical role in how the ovary responds to obesity-related metabolic stress, further supporting its dispensability in this context.
Discussion and Conclusion
Despite being a strong risk gene in humans, Thada appears to be dispensable for basic fertility in mice. This suggests that the reproductive system possesses significant functional redundancy or that THADA's role is more subtle than a simple switch for fertility. The results reinforce the idea that PCOS is a multifactorial, polygenic disease where a single susceptibility gene may only contribute a small fraction of the overall risk.
Limitations of the study include potential species-specific differences in THADA function and the focus on the ovary, whereas the gene's contribution to PCOS might be mediated through the hypothalamus-pituitary-ovarian axis or metabolic regulation in other organs. Future work could explore alternative stressors, such as prenatal androgen exposure, to further investigate the gene's role in PCOS pathogenesis.
Summary updated